Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

NCT04575584 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

304

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Coronavirus Disease (COVID-19)

Interventions

DRUG: Molnupiravir
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC